Arthur Sands is President, Chief Executive Officer and Director of Nurix Therapeutics, Inc. (NRIX). The company reported total compensation of $6,374,138 for fiscal year 2025.
| Salary | $674,584 |
|---|---|
| Bonus | $0 |
| Stock awards | $0 |
| Option awards | $5,166,196 |
| Non-equity incentive plan | $510,000 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $23,358 |
| Total | $6,374,138 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Nurix Therapeutics, Inc. filed March 27, 2026, accession 0001140361-26-011492.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | President, Chief Executive Officer and Director | $674,584 | $0 | $0 | $5,166,196 | $510,000 | $0 | $23,358 | $6,374,138 |
| FY2024 | President, Chief Executive Officer and Director | $613,104 | $0 | $0 | $4,751,716 | $424,350 | $0 | $23,692 | $5,812,862 |
| FY2023 | President, Chief Executive Officer and Director | $590,813 | $0 | $0 | $3,376,799 | $355,350 | $0 | $40,158 | $4,363,120 |
Totals as disclosed in each year's own compensation disclosure for Nurix Therapeutics, Inc..
| Peer-group chief executive median | $5,366,709 |
|---|---|
| Difference from that median | $1,007,429 |
| Percentile within the disclosed peer group | 67th |
| Peers with a disclosed figure | 3 |
Medians and percentiles are computed across the peer group Nurix Therapeutics, Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Arthur Sands this page | President, Chief Executive Officer and Director | $6,374,138 |
| Gwenn Hansen | Chief Scientific Officer | $2,498,124 |
| Hans van Houte | Chief Financial Officer | $2,296,503 |
| Christine Ring | Chief Legal Officer and Chief Compliance Officer | $2,263,337 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Nurix Therapeutics, Inc. compensation brief.
Arthur Sands's compensation sits inside Nurix Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.